Russell Investments Group, Ltd. Prothena Corp Public LTD CO Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 995 shares of PRTA stock, worth $11,890. This represents 0.0% of its overall portfolio holdings.

Number of Shares
995
Previous 1,751 43.18%
Holding current value
$11,890
Previous $36,000 55.56%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$16.73 - $24.79 $12,647 - $18,741
-756 Reduced 43.18%
995 $16,000
Q2 2024

Aug 08, 2024
BUY
$19.54 - $26.15 $31,674 - $42,389
1,621 Added 1246.92%
1,751 $36,000
Q1 2024

May 08, 2024
SELL
$24.75 - $40.66 $6,237 - $10,246
-252 Reduced 65.97%
130 $3,000
Q4 2023

Feb 05, 2024
BUY
$32.31 - $52.32 $12,342 - $19,986
382 New
382 $13,000
Q1 2022

May 05, 2022
SELL
$30.27 - $49.22 $717,731 - $1.17 Million
-23,711 Closed
0 $0
Q4 2021

Jan 21, 2022
BUY
$42.11 - $73.26 $851,253 - $1.48 Million
20,215 Added 578.23%
23,711 $1.17 Million
Q3 2021

Nov 08, 2021
BUY
$48.2 - $78.89 $168,507 - $275,799
3,496 New
3,496 $249,000
Q2 2021

Aug 04, 2021
SELL
$21.63 - $57.65 $1.41 Million - $3.75 Million
-65,119 Closed
0 $0
Q1 2021

May 10, 2021
SELL
$11.0 - $28.24 $302,907 - $777,644
-27,537 Reduced 29.72%
65,119 $1.63 Million
Q4 2020

Feb 08, 2021
SELL
$10.12 - $13.94 $36,806 - $50,699
-3,637 Reduced 3.78%
92,656 $1.11 Million
Q3 2020

Nov 09, 2020
SELL
$9.93 - $13.47 $153,329 - $207,990
-15,441 Reduced 13.82%
96,293 $960,000
Q2 2020

Aug 05, 2020
BUY
$9.56 - $12.51 $174,144 - $227,882
18,216 Added 19.48%
111,734 $1.17 Million
Q1 2020

May 06, 2020
BUY
$7.54 - $15.77 $97,303 - $203,511
12,905 Added 16.01%
93,518 $999,000
Q4 2019

Jan 29, 2020
BUY
$7.48 - $17.01 $194,577 - $442,481
26,013 Added 47.64%
80,613 $1.28 Million
Q3 2019

Nov 01, 2019
SELL
$6.89 - $10.45 $61,072 - $92,628
-8,864 Reduced 13.97%
54,600 $428,000
Q2 2019

Aug 09, 2019
SELL
$8.85 - $12.49 $136,174 - $192,183
-15,387 Reduced 19.51%
63,464 $671,000
Q1 2019

May 13, 2019
BUY
$10.32 - $14.49 $219,826 - $308,651
21,301 Added 37.01%
78,851 $956,000
Q4 2018

Feb 11, 2019
BUY
$8.73 - $13.74 $50,974 - $80,227
5,839 Added 11.29%
57,550 $593,000
Q3 2018

Oct 26, 2018
BUY
$12.7 - $15.79 $249,516 - $310,226
19,647 Added 61.27%
51,711 $676,000
Q1 2018

May 11, 2018
BUY
$27.95 - $45.04 $278,242 - $448,373
9,955 Added 45.03%
32,064 $1.18 Million
Q4 2017

Feb 06, 2018
SELL
$35.44 - $63.76 $539,255 - $970,172
-15,216 Reduced 40.77%
22,109 $840,000
Q3 2017

Nov 07, 2017
BUY
$53.83 - $67.75 $2.01 Million - $2.53 Million
37,325
37,325 $2.42 Million

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $561M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email